Nihon Kohden Corporation (OTCMKTS:NHNKY – Get Free Report) was the target of a significant decrease in short interest in the month of April. As of April 30th, there was short interest totaling 21,619 shares, a decrease of 90.5% from the April 15th total of 226,933 shares. Based on an average daily trading volume, of 54,689 shares, the short-interest ratio is presently 0.4 days. Approximately 0.0% of the company’s shares are short sold.
Analyst Upgrades and Downgrades
NHNKY has been the subject of a number of analyst reports. Zacks Research raised shares of Nihon Kohden to a “hold” rating in a report on Monday, April 27th. UBS Group upgraded Nihon Kohden from a “hold” rating to a “strong-buy” rating in a research report on Monday, January 19th. One research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Buy”.
Read Our Latest Stock Analysis on NHNKY
Nihon Kohden Trading Up 1.6%
Nihon Kohden (OTCMKTS:NHNKY – Get Free Report) last issued its quarterly earnings data on Thursday, February 5th. The company reported $0.16 earnings per share (EPS) for the quarter. Nihon Kohden had a net margin of 5.32% and a return on equity of 7.25%. The firm had revenue of $362.86 million during the quarter. On average, equities analysts anticipate that Nihon Kohden will post 0.48 EPS for the current fiscal year.
About Nihon Kohden
Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.
The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.
Featured Stories
- Five stocks we like better than Nihon Kohden
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
- MercadoLibre Boldly Invests in Growth: Discount Deepens
Receive News & Ratings for Nihon Kohden Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nihon Kohden and related companies with MarketBeat.com's FREE daily email newsletter.
